SN

Sripathi Narayana Balekummeri

Active Director Director DIN 07341274
DIN 07341274 First appointment Dec 2015 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Sripathi Narayana Balekummeri

Data last updated:

Sripathi Narayana Balekummeri is a Director at Yolo Pharma Private Limited (since 2015). The company operates in Business Services.

DIN 07341274
Primary Designation Director
Industry Business Services
First Appointment 11 Dec 2015
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Yolo Pharma Private Limited U74900KA2015PTC084674
Director11 Dec 20152015Active

Board colleagues of Sripathi Narayana Balekummeri

NameDINCompanyDesignation
Nagaraj Mandya Manjunatha07341275Yolo Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Yolo Pharma Private Limited
Premium access

Shareholding and investment profile for Sripathi Narayana Balekummeri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sripathi Narayana Balekummeri

Sripathi Narayana Balekummeri currently holds 1 directorship: Yolo Pharma Private Limited (Director, since 11 Dec 2015).

Sripathi Narayana Balekummeri was first appointed on 11 Dec 2015 as Director at Yolo Pharma Private Limited.

The current boards of Sripathi Narayana Balekummeri's companies include Nagaraj Mandya Manjunatha (Yolo Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available